Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 297 results for "kexin"

Sichuan Kexin Mechanical and Electrical Equipment lowers 2015 ...

Sichuan Kexin Mechanical and Electrical Equipment Co Ltd:Sees net profit for 2015 to be -32.5 million yuan to -37 million yuan.In the previous outlook, the company expected the net profit for 2015 to be -28 million yuan to -33 million yuan.Says the ... Reuters, 1 week ago
Xinhua News Agency

Fan wins women's 1,500m short-track speedskating with world record time at National Winter Games

URUMQI, Jan. 21 (Xinhua) -- Olympic silver medalist Fan Kexin clocked two minutes 16.024 seconds to win the women's 1,500-meter gold medal at the 13th National Winter Games of China, surpassing the previous world record by more than half a second. ...
 Xinhua News Agency2 weeks ago Fan Kexin wins 1,500m short-track speedskating  China.org.cn2 weeks ago Fan Kexin wins women's 500m at ISU World Cup Short Track speed skating event  Xinhua News Agency1 month ago China's Fan wins women's 500m at ISU World Cup Short Track  China Economic Net1 month ago
[x]  

Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study

John J.P. Kastelein Department of Vascular Medicine , Academic Medical Center of the University of Amsterdam , Meibergdreef 9, Room F4-159.2, 1105 AZ Amsterdam , The Netherlands Steven E. Nissen Cleveland Clinic Heart and Vascular ...
 European Heart Journal3 weeks ago The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors  European Heart Journal1 month ago Low adherence rates to cholesterol lowering medications may lead to health, cost concerns  Cardiovascular Business1 month ago

PCSK9 Inhibitors for Treatment of High Cholesterol Levels

Extract This evidence summary reviews the comparative clinical effectiveness of proprotein convertase subtilisin/kexin type 9 inhibitor for the treatment of adults with familial hypercholesterolemia or cardiovascular disease and who require ...
 JAMA Internal Medicine1 month ago
PR Newswire

PCSK9 Inhibitors Set to Achieve Blockbuster Status Despite Constraints on Use

BURLINGTON, Mass., Dec. 16, 2015 /PRNewswire/ -- finds that the recently launched proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor class will be a key driver in the growth of the dyslipidemia and acute coronary syndrome (ACS) markets ...
 Financial Content1 month ago
[x]  
Monthly Prescribing Reference

Top-line Results Announced for Repatha in Patients Who Are Statin-Intolerant

Share this article: Full detailed results from GAUSS-3 will be revealed at a future medical conference Amgen announced positive top-line data from the Phase 3 GAUSS-3 study evaluating Repatha (evolocumab) in statin-intolerant patients ...
 Monthly Prescribing Reference10 hours ago Top-line Results from Repatha Phase 3 Study Announced  Renal & Urology News12 hours ago
European Pharmaceutical Review

Positive topline results from GAUSS-3 trial of Repatha

The Phase 3 GAUSS-3 trial evaluating Amgen's Repatha (evolocumab) in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints. The primary endpoints were mean percent reductions from baseline in low-density ...
 European Pharmaceutical Review16 hours ago AMGEN : Positive topline results from GAUSS-3 trial of Repatha  4 Traders10 hours ago
Nasdaq

Amgen Announces Positive TopLine Results From Phase 3 GAUSS3 Trial Of Repatha Evolocumab In StatinIntolerant Patients With High Cholesterol

Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha® (Evolocumab) In Statin-Intolerant Patients With High Cholesterol Thursday, February 04, 2016 THOUSAND OAKS, Calif. , Feb. 4, 2016 /PRNewswire/ --Amgen ...
 Pharma Focus Asia1 day ago Amgen (AMGN)'s Repatha Met Co-Primary Endpoints in Phase III GAUSS-3 Study 2/5/2016  ClinicSpace1 day ago Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha┬« (Evolocumab) In Statin-Intolerant Patients With High Cholesterol  Sys-Con Italia1 day ago Amgen's Repatha Evolocumab Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol  Pharmacy Choice2 days ago
[x]  

Best candidates for PCSK9 inhibitors

Starting in December 2013, pharmacy benefits managers (PBMs) and insurers scrambled to decide which of the new hepatitis C drugs to put on their formularies. The efforts provided a test run for many in determining which of the two new PCSK9 drugs to ...
 Managed Healthcare Executive1 day ago

Outdoor ceremony brings China's National Winter Games to close in Xinjiang

URUMQI, Jan. 30 (Xinhua) -- A splendid outdoor ceremony at the Silk Road ski resort brought to close the 13th Chinese National Winter Games Saturday afternoon, which is an opportunity to help build interest in winter sport in the country's build-up ...
 Xinhua News Agency1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less